590 related articles for article (PubMed ID: 17897902)
21. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
[TBL] [Abstract][Full Text] [Related]
22. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
[TBL] [Abstract][Full Text] [Related]
23. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
24. An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma.
Cordella D; Muzza M; Alberti L; Colombo P; Travaglini P; Beck-Peccoz P; Fugazzola L; Persani L
Endocr Relat Cancer; 2006 Sep; 13(3):945-53. PubMed ID: 16954442
[TBL] [Abstract][Full Text] [Related]
25. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.
Mise N; Drosten M; Racek T; Tannapfel A; Pützer BM
Oncogene; 2006 Oct; 25(50):6637-47. PubMed ID: 16715139
[TBL] [Abstract][Full Text] [Related]
27. A novel deletion in the RET proto-oncogene found in sporadic medullary thyroid carcinoma.
Alemi M; Lucas SD; Sällström JF; Akerström G; Wilander E
Anticancer Res; 1996; 16(5A):2619-22. PubMed ID: 8917360
[TBL] [Abstract][Full Text] [Related]
28. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
[TBL] [Abstract][Full Text] [Related]
29. [Is immediate prophylactic thyroidectomy indispensable in familiar medullary thyroid carcinoma?].
Cañizo A; Fanjul M; Cerdá J; Menárguez J; Parente A; Laín A; Carrera N; Rodríguez-Arnao MD; Rodríguez-Sánchez A; Polo JR; Vázquez J
Cir Pediatr; 2008 Apr; 21(2):100-3. PubMed ID: 18624279
[TBL] [Abstract][Full Text] [Related]
30. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family].
Benazzouz B; Hafidi A; Benkhira S; Chraibi A; Kadiri A; Hilal L
Bull Cancer; 2008 Apr; 95(4):457-63. PubMed ID: 18495576
[TBL] [Abstract][Full Text] [Related]
31. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
Krampitz GW; Norton JA
Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
[TBL] [Abstract][Full Text] [Related]
32. Cellular effects of imatinib on medullary thyroid cancer cells harboring multiple endocrine neoplasia Type 2A and 2B associated RET mutations.
de Groot JW; Plaza Menacho I; Schepers H; Drenth-Diephuis LJ; Osinga J; Plukker JT; Links TP; Eggen BJ; Hofstra RM
Surgery; 2006 Jun; 139(6):806-14. PubMed ID: 16782438
[TBL] [Abstract][Full Text] [Related]
33. Molecular diagnosis of multiple endocrine neoplasia Type 2.
Bugalho MJ; Domingues R; Sobrinho L
Expert Rev Mol Diagn; 2003 Nov; 3(6):769-79. PubMed ID: 14628904
[TBL] [Abstract][Full Text] [Related]
34. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
Shaha AR; Cohen T; Ghossein R; Tuttle RM
Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
[TBL] [Abstract][Full Text] [Related]
35. [Medullary carcinoma of thyroid gland].
Spinelli C; Galleri D; Calbo L; Palmeri R; Miccoli P; Melita P
Chir Ital; 1997; 49(4-5):21-5. PubMed ID: 10392179
[TBL] [Abstract][Full Text] [Related]
36. Very early prophylactic thyroid surgery for infants with a mutation of the RET proto-oncogene at codon 634: evaluation of the implementation of international guidelines for MEN type 2 in a single centre.
Piolat C; Dyon JF; Sturm N; Pinson S; Bost M; Jouk PS; Plantaz D; Chabre O
Clin Endocrinol (Oxf); 2006 Jul; 65(1):118-24. PubMed ID: 16817830
[TBL] [Abstract][Full Text] [Related]
37. Medullary thyroid cancer.
You YN; Lakhani V; Wells SA; Moley JF
Surg Oncol Clin N Am; 2006 Jul; 15(3):639-60. PubMed ID: 16882502
[TBL] [Abstract][Full Text] [Related]
38. [Familial thyroid medullary carcinoma without associated neoplasms].
Lisa Catón V; Peña Somovilla JL; Ochoa Gómez FJ; Salcedo Aguilar FJ; Vilella Morato A; Campo Hernández JM
An Med Interna; 1994 Sep; 11(9):452-4. PubMed ID: 7858091
[TBL] [Abstract][Full Text] [Related]
39. Genetic aspects of familial thyroid cancer.
Morrison PJ; Atkinson AB
Oncologist; 2009 Jun; 14(6):571-7. PubMed ID: 19465682
[TBL] [Abstract][Full Text] [Related]
40. Current management of medullary thyroid cancer.
Sippel RS; Kunnimalaiyaan M; Chen H
Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]